InvestorsHub Logo
Followers 0
Posts 24
Boards Moderated 0
Alias Born 06/14/2018

Re: None

Saturday, 01/05/2019 4:05:41 AM

Saturday, January 05, 2019 4:05:41 AM

Post# of 426359
Best line from this vent out-fest...
Management Sells, Vascepa doesn't!

My 2 cents...
Management thought they would sit back after September 24th and let the BO offers come raining in. They got complacent. No BO offers ever came! They're now realizing a BO offer won't be coming for awhile. Too many issues have yet to be resolved: label change when you're not an FDA favorite, partnerships with other countries, abysmal sales since the AHA, keeping shareholders completely in the dark for the longest time, management consistently selling. I understand they need to be compensated but to sell your options at these depressed prices (50% off the highs) means a lot for what they think of the future PPS.

But this Friday AH news release takes the cake! Who releases a Friday AH NR without thinking it's bad news. The NR was decent however to have them slip it under the rug like this is a very bad sign of what things will become.

This management team is way over their heads with the promotion of this product. Monday I'm selling half my holdings solely on the management team running this circus. I believe in the product but this team simply cannot get Vascepa to the next level. How do you sell it to hedge funds managers this week when the PPS since the AHA has consistently dropped week after week? There's always some excuse for the weekly drops!

Btw: I'm not here for a BO, but I do believe the product sales should be A LOT HIGHER than what we're seeing..and consequently a much higher PPS!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News